Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms of Cannabidiol (CBD) in Persons With Multiple Sclerosis (MS): the Role of Sleep and Pain Phenotype

NCT05269628 is registered in ClinicalTrials.gov with Tiffany J. Braley, MD, MS as lead sponsor.

NCT NCT05269628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05269628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms of Cannabidiol (CBD) in Persons With Multiple Sclerosis (MS): the Role of Sleep and Pain Phenotype
Lead sponsor
Tiffany J. Braley, MD, MS
Phase
Phase 2
Overall status
Recruiting
Start date
March 25, 2022
Completion date
August 30, 2027
Enrollment
166 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, pain, sleep